 Teva Pharma inked settlement deals worth upward of 4 billion for its role in the opioid crisis, and Teva stock skyrocketed on Wednesday. The post Teva Pharmaceutical Soars After Inking More Than 4 Billion In Opioid Deals appeared first on Investors Business Daily. 